يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"ENFERMEDADES::enfermedades del sistema nervioso::enfermedades neurodegenerativas"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Llorián Salvador M Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, Northern Ireland, UK. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. de Fuente AG Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, Northern Ireland, UK. Institute for Health and Biomedical Research of Alicante (ISABIAL) Alicante, Alicante, Spain. Instituto de Neurociencias CSIC-UMH, San Juan de Alicante, Alicante, Spain. McMurran CE Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. Dashwood A Babraham Institute, Cambridge, UK. Department of Pathology, University of Cambridge, Cambridge, UK. Dooley J, Liston A Department of Pathology, University of Cambridge, Cambridge, UK, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Molecular Neurodegeneration;19(1); https://doi.org/10.1186/s13024-024-00724-wTest; Llorián-Salvador M, de Fuente AG, McMurran CE, Dashwood A, Dooley J, Liston A, et al. Regulatory T cells limit age-associated retinal inflammation and neurodegeneration. Mol Neurodegener. 2024 Apr 5;19(1):32.; https://hdl.handle.net/11351/11323Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Hamdon S, Omar MY, Gil C Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Spain. Institut de Neurociències, Universitat Autònoma de Barcelona, Spain. Fernandez-Gonzalez P Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Spain. González-Sepúlveda M Grup de Recerca de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, USA. Ortiz J Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Spain. Institut de Neurociències, Universitat Autònoma de Barcelona, Spain. Centro Investigación Biomédica en Red de Salud Mental, CIBERSAM, and Translational Neuroscience Unit, Parc Taulí University Hospital and Universitat Autònoma de Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Neuropharmacology;242; https://doi.org/10.1016/j.neuropharm.2023.109759Test; Hamdon S, Fernandez-Gonzalez P, Omar MY, González-Sepúlveda M, Ortiz J, Gil C. CHIR99021 causes inactivation of Tyrosine Hydroxylase and depletion of dopamine in rat brain striatum. Neuropharmacology. 2024 Jan 1;242:109759.; https://hdl.handle.net/11351/10972Test; 001121064400001

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Valdor R Immunology-Cell Therapy and Hematopoietic Transplant Group, Department of Biochemistry and Molecular Biology B, University of Murcia (UMU), Murcia, Spain. Unit of Autophagy, Immune Response and Tolerance in Pathologic Processes, Biomedical Research Institute of Murcia-Pascual Parrilla (IMIB), Murcia, Spain. Martinez-Vicente M Laboratori d’Autofagia i Disfunció Lisosomal, Grup de Recerca de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERNED, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Biomedicines;12(2); https://doi.org/10.3390/biomedicines12020257Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F00728; Valdor R, Martinez-Vicente M. The Role of Chaperone-Mediated Autophagy in Tissue Homeostasis and Disease Pathogenesis. Biomedicines. 2024 Jan 23;12(2):257.; https://hdl.handle.net/11351/11145Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Sanchez-Tejerina D, Juntas-Morales R Unitat de Trastorns Neuromusculars, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca del Sistema Nerviós Perifèric, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Vall d’Hebron Barcelona Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Llaurado A, Sotoca J, Lopez-Diego V, Salvado M Unitat de Trastorns Neuromusculars, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca del Sistema Nerviós Perifèric, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Vall d’Hebron Barcelona Hospital Universitari, Barcelona, Spain. Vidal Taboada JM Grup de Recerca del Sistema Nerviós Perifèric, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cells;12(8); https://doi.org/10.3390/cells12081180Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00593; Sanchez-Tejerina D, Llaurado A, Sotoca J, Lopez-Diego V, Vidal Taboada JM, Salvado M, et al. Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications. Cells. 2023 Apr 18;12(8):1180.; https://hdl.handle.net/11351/9585Test; 000979145000001

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Laguna A Grup d'Investigació en Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. Xicoy H Grup d'Investigació en Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Neuroscience, Faculty of Science, Nijmegen, The Netherlands. Tolosa E, Vilas D Parkinson Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona IDIBAPS, CIBERNED: CB06/05/0018-ISCIII, Barcelona, Spain. Serradell M, Gaig C Center for Sleep Disorders, Neurology Service, Hospital Clinic Barcelona, Universitat de Barcelona, IDIBAPS, CIBERNED: CB06/05/0018-ISCIII, Barcelona, Spain. Vila M Grup d'Investigació en Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: npj Parkinsons Disease;7; https://doi.org/10.1038/s41531-021-00184-9Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI13%2F01897; info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2015-73997-JIN; info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2016-77541-R; Laguna A, Xicoy H, Tolosa E, Serradell M, Vilas D, Gaig C, et al. Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder. NPJ Parkinsons Dis. 2021 May 13;7:40.; https://hdl.handle.net/11351/6804Test; 000650054000002

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Meca-Lallana V Multiple Sclerosis Unit, Neurology Department, Fundación de Investigación Biomédica, Hospital Universitario de la Princesa, Madrid, Spain. Berenguer-Ruiz L Neurology Department, Hospital Marina Baixa, Alicante, Spain. Carreres-Polo J Neuroradiology Section, Radiology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Eichau-Madueño S Multiple Sclerosis CSUR Unit, Neurology Department, Hospital Universitario Virgen Macarena, Seville, Spain. Ferrer-Lozano J Department of Pathology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Forero L Neurology Department, Hospital Puerta del Mar, Cádiz, Spain. Vidal-Jordana A Servei de Neurologia/Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Neurology;12; https://doi.org/10.3389/fneur.2021.608491Test; Meca-Lallana V, Berenguer-Ruiz L, Carreres-Polo J, Eichau-Madueño S, Ferrer-Lozano J, Forero L, et al. Deciphering Multiple Sclerosis Progression. Front Neurol. 2021 Apr;12:608491.; https://hdl.handle.net/11351/6729Test; 000641706300001

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, García-Muñoz E Banc de Sang i Teixits, 08005 Barcelona, Spain. Vives J Banc de Sang i Teixits, 08005 Barcelona, Spain. Grup d'Enginyeria de Teixits Musculoesquelètics, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cytotechnology;73; https://doi.org/10.1007/s10616-021-00474-3Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788; García-Muñoz E, Vives J. Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use. Cytotechnology. 2021 Jun;73:513–522.; https://hdl.handle.net/11351/7095Test; 000648804900001

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Sancho P, Martínez-Rubio D Unit of Rare Neurodegenerative Diseases, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain. Andrés-Bordería A Unit of Rare Neurodegenerative Diseases, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain. Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain. Gorría-Redondo N, Yoldi-Petri ME Pediatric Neurology Unit, Department of Pediatrics, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain. Pérez-Dueñas B Grup de Recerca en Neurologia Pediàtrica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: International Journal of Molecular Sciences;22(5); https://doi.org/10.3390/ijms22052505Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00147; Sancho P, Andrés-Bordería A, Gorría-Redondo N, Llano K, Martínez-Rubio D, Yoldi-Petri ME, et al. Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration. Int J Mol Sci. 2021 Mar 2;22(5):2505.; https://hdl.handle.net/11351/6571Test; 000628287200001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Machuca C Unit of Rare Neurodegenerative Diseases, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Rare Diseases Joint Units, CIPF-IIS La Fe & INCLIVA, Valencia, Spain. Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Correa-Vela M Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. García-Navas D Department of Pediatric Neurology. Hospital Universitario San Pedro de Alcántara, Cáceres, Spain. Darling A Unit of Pediatric Movement Disorders, Hospital Sant Joan de Déu, Barcelona, Spain. Villalón-García I, Sánchez-Alcázar JA Centro Andaluz de Biología del Desarrollo (CABD-CSIC), Universidad Pablo de Olavide, Seville, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Pérez-Dueñas B Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Stem Cell Research;53; https://doi.org/10.1016/j.scr.2021.102338Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01319; Machuca C, Correa-Vela M, García-Navas D, Darling A, Villalón-García I, Sánchez-Alcázar JA, et al. Generation of three human iPSC lines from PLAN (PLA2G6-associated neurodegeneration) patients. Stem Cell Res. 2021 May;53:102338.; https://hdl.handle.net/11351/6763Test; 000663439300012

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Cano A Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain. Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Nanoscience and Nanotechnology (IN2UB), 08028 Barcelona, Spain. Fonseca E, Toledo M Unitat d’Epilèpsia, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Estat Epilèptic i Convulsions Agudes, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ettcheto M Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Neurosciences (UBNeuro), University of Barcelona, 08007 Barcelona, Spain. Sánchez-López E Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain. Institute of Nanoscience and Nanotechnology (IN2UB), 08028 Barcelona, Spain. de Rojas I Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain. Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain. Alonso-Lana S Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), 08029 Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Pharmaceuticals;14(10); https://doi.org/10.3390/ph14101057Test; Cano A, Fonseca E, Ettcheto M, Sánchez-López E, Rojas I de, Alonso-Lana S, et al. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals. 2021 Oct;14(10):1057.; https://hdl.handle.net/11351/7488Test; 000716873000001